Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mackinnon

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
Blood|January 13, 1999
Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusionsT N Small, E B Papadopoulos, F Boulad, et al.
Bone Marrow Transplantation|January 14, 2009
Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: conditioning protocols and donor selection algorithmsB E Shaw, P Veys, A Pagliuca, et al.
Bone Marrow Transplantation|January 17, 2017
Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplantsB E Shaw, N P Mayor, R M Szydlo, et al.
Leukemia|November 20, 2009
Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA allelesB E Shaw, N P Mayor, N H Russell, et al.
Bone Marrow Transplantation|August 30, 2008
Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplantB E Shaw, G J Mufti, S Mackinnon, et al.
Blood|February 3, 1998
T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host diseaseE B Papadopoulos, M H Carabasi, H Castro-Malaspina, et al.
Cytotherapy|August 13, 2002
In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantationP D Kottaridis, D W Milligan, R Chopra, et al.
Clinical Genetics|March 13, 2016
Expanding the genotypic spectrum of Perrault syndromeL A M Demain, J E Urquhart, J O'Sullivan, et al.
Blood|September 26, 2000
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantationP D Kottaridis, D W Milligan, R Chopra, et al.
Scientific Reports|December 3, 2021
Multiscale interactome analysis coupled with off-target drug predictions reveals drug repurposing candidates for human coronavirus diseaseMichael G Sugiyama, Haotian Cui, Dar'ya S Redka, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
Blood|January 13, 1999
Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusionsT N Small, E B Papadopoulos, F Boulad, et al.
Bone Marrow Transplantation|January 14, 2009
Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: conditioning protocols and donor selection algorithmsB E Shaw, P Veys, A Pagliuca, et al.
Bone Marrow Transplantation|January 17, 2017
Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplantsB E Shaw, N P Mayor, R M Szydlo, et al.
Leukemia|November 20, 2009
Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA allelesB E Shaw, N P Mayor, N H Russell, et al.
Bone Marrow Transplantation|August 30, 2008
Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplantB E Shaw, G J Mufti, S Mackinnon, et al.
Blood|February 3, 1998
T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host diseaseE B Papadopoulos, M H Carabasi, H Castro-Malaspina, et al.
Cytotherapy|August 13, 2002
In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantationP D Kottaridis, D W Milligan, R Chopra, et al.
Clinical Genetics|March 13, 2016
Expanding the genotypic spectrum of Perrault syndromeL A M Demain, J E Urquhart, J O'Sullivan, et al.
Blood|September 26, 2000
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantationP D Kottaridis, D W Milligan, R Chopra, et al.
Scientific Reports|December 3, 2021
Multiscale interactome analysis coupled with off-target drug predictions reveals drug repurposing candidates for human coronavirus diseaseMichael G Sugiyama, Haotian Cui, Dar'ya S Redka, et al.
Pageof 13